Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

MILES, JOHN

NPI: 1528263647 · RANSON, WV 25438 · Anesthesiology Physician · NPI assigned 06/19/2007

$142K
Total Medicaid Paid
6,776
Total Claims
5,683
Beneficiaries
17
Codes Billed
2018-01
First Month
2018-07
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 6,776 $142K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 641 578 $44K
96102 1,237 1,094 $21K
G0396 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes 1,653 1,447 $19K
96103 1,536 1,366 $18K
93923 244 75 $16K
96120 484 439 $11K
95924 117 72 $5K
95923 43 27 $3K
99401 84 44 $2K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 234 216 $2K
93040 121 75 $985.62
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 72 66 $714.17
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 103 95 $696.11
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 69 31 $36.30
97012 34 13 $11.16
97530 Therapeutic activities, direct patient contact, each 15 minutes 70 32 $0.00
97010 34 13 $0.00